Collectively, this treatment strategy comprised of selective blockade of IL-6 signal with anti-IL-6R blocking antibody could be effective and ideal for treating PD-1 signal blockade-induced psoriasis-like dermatitis. This evidence concerns the gene IL6R and psoriasis.